Invitae Corp. started an underwritten public offering of $50.0 million of its common stock.
The San Francisco-based genetic information company plans to grant the underwriters an option to buy up to an additional $7.5 million of common stock.
J.P. Morgan Securities LLC and Cowen and Co. LLC are acting as the joint book-running managers, while William Blair & Co. LLC is acting as the lead manager for the offering.